Categories
- DATA SCIENCE / AI
- AFIR / ERM / RISK
- ASTIN / NON-LIFE
- BANKING / FINANCE
- DIVERSITY & INCLUSION
- EDUCATION
- HEALTH
- IACA / CONSULTING
- LIFE
- PENSIONS
- PROFESSIONALISM
- THOUGHT LEADERSHIP
- MISC
ICA LIVE: Workshop "Diversity of Thought #14
Italian National Actuarial Congress 2023 - Plenary Session with Frank Schiller
Italian National Actuarial Congress 2023 - Parallel Session on "Science in the Knowledge"
Italian National Actuarial Congress 2023 - Parallel Session with Lutz Wilhelmy, Daniela Martini and International Panelists
Italian National Actuarial Congress 2023 - Parallel Session with Kartina Thompson, Paola Scarabotto and International Panelists
3 views
0 comments
0 likes
0 favorites
With the outbreak of Covid-19 pandemic, the Brazilian supplementary healthcare sector became a conducive environment for using complex data analysis and modeling tools. In this study, we apply different Machine and Deep Learning techniques (SVM, XGBoost and RNN) to predict healthcare expenses and evaluate if these techniques would present better performance in comparison to traditional ones, such as time series and regressions. Prediction scenarios were generated upon expense official databases between 2015-2022, considering two panoramas: (i) real, and; (ii) counterfactual, in which we assume the non-existence of the pandemic data for 2020. Using RMSE as the performance indicator, we find out that XGBoost model presented the best performance for the real panorama, with better fit in 32.2% of the scenarios. For the counterfactual panorama, we observe that RNN and SVM models obtained better fit in 22.3% of the cases. It is noteworthy that, until now, no studies were identified that address the use of predictive Machine and Deep Learning models into the Brazilian healthcare expenses. We also expect that this study offers insights for decisions made by the several players in this sector, such as operators and regulators, especially when it comes to pricing and development of healthcare products.
0 Comments
There are no comments yet. Add a comment.